IL17A and Hepatic fibrosis: A recent study has demonstrated that IL-17A overexpression upregulates fibroblast activation protein-α expression, a critical regulator of HSC activation, thereby promoting liver fibrosis and tumorigenesis in both in vivo and in vitro experimental models (123).